期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Diagnosis and Treatment of Cholangiocarcinoma: A Consensus from Surgical Specialists of China 被引量：2

Diagnosis and Treatment of Cholangiocarcinoma: A Consensus from Surgical Specialists of China
下载PDF
导出
摘要 Cholangiocarcinoma refers to malignant tumors that develop in epithelial lining of biliary system, and it is divided into two categories according to tumor location, intrahepatic cholangiocarcinoma （ICC） and extrahepatic cholangiocarcinoma （ECC）. ICC occurs from the epithelial cells of the intrahepatic bile duct, its branches and interlobular biliary tree; and ECC is divided into hilar cholangiocarcinoma and distal cholangiocarcinoma by the circumscription at the confluence of cystic duct and the common hepatic duct. Cholangiocarcinoma refers to malignant tumors that develop in epithelial lining of biliary system, and it is divided into two categories according to tumor location, intrahepatic cholangiocarcinoma （ICC） and extrahepatic cholangiocarcinoma （ECC）. ICC occurs from the epithelial cells of the intrahepatic bile duct, its branches and interlobular biliary tree; and ECC is divided into hilar cholangiocarcinoma and distal cholangiocarcinoma by the circumscription at the confluence of cystic duct and the common hepatic duct.
作者 Jian-qiang Cai Shou-wang Cai Wen-ming Cong Min-shan Chen Ping Chen Xiao-ping Chen Yan-ling Chen Yi-fa Chen Chao-liu Dai Qiang Huang Zhi-yong Huang Bo Jiang Bin Jiang Ke-wei Jiang Bo Li Zong-fangLi Li-jian Liang Bin Liu Hui-chun Liu Lian-xin Liu Qing-guang Liu Rong Liu Ying-bin Liu Jian-guo Lu Shi-chun Lu Yi Lu Yi-lei Mao Bin Mei Jun Niu Bao-gang Peng Xiao Qin Yu-dong Qiu Guang-yi Wang Yao-don Wangg Zhi-ming Wang Ren-hua Wan Ya-fu Wu Bao-cai Xing Feng Xia Ge-liang Xu Jia-mei Yang Xiao-fang Yu Yong Zeng Yong-yi Zeng Bi-xiang Zhang Bin-hao Zhang Qi-yu Zhang Shui-jun Zhang Wan-guang Zhang Yong-jie Zhang Zhi-wei Zhang Dong Zhou Wei-ping Zhou
机构地区 Cancer Institute and Hospital Chinese PLA General Hospital Eastern Hepatobiliary Surgery Hospital of Second Military Medical University Sun Yat-sen University Cancer Center Daping Hospital of Third Military Medical University Tongji Hospital Fujian Medical University Union Hospital Shengjing Hospital of China Medical University Anhui Provincial Hospital Hunan Provincial People’s Hospital Taihe Hospital Affiliated to Hubei University of Medicine Peking University People’s Hospital West China Hospital The Second Affiliated Hospital of Xi’an Jiao Tong University The First Affiliated Hospital First Affiliated Hospital of Kunming Medical University The First Affiliated Hospital of Bengbu Medical College The First Affiliated Hospital of Harbin Medical University The First Affiliated Hospital of Xi’an Jiao Tong University Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Tangdu Hospital of Fourth Military Medical University Peking Union Medical College Hospital Qilu Hospital of Shandong University The First Affiliated Hospital of Guangxi Medical University Nanjing Drum Tower Hospital The First Affiliated Hospital of Jilin University Fujian Provincial Hospital Xiangya Hospital of Central South University The First Affiliated Hospital of Nanchang University Beijing Cancer Hospital Southwest Hospital of Third Military Medical University Shenzhen People’s Hospital The First Affiliated Hospital of Fujian Medical University The First Affiliated Hospital of Wenzhou Medical University The First Affiliated Hospital of Zhengzhou University Fujian Provincial Cancer Hospital
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2014年第4期469-475,共7页 华中科技大学学报（医学英德文版）
关键词 A Consensus from Surgical Specialists of China Diagnosis and Treatment of Cholangiocarcinoma
分类号 R735.8 [医药卫生—肿瘤]
  • 相关文献

参考文献26

  • 1Bismuth HCD. Hepatobiliary malignancy. London: Edward Arnold, 1994.
  • 2O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl, 2000,6(6 suppl 2):S23-S2 9.
  • 3de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med, 1999,341(18): 1368-1378.
  • 4Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates from intrahepatic cholangi- ocarcinoma in England and Wales 1968-1998. Gut, 2001,48(6):816-820.
  • 5Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oneol, 1999,10 (Suppl 4):308-311.
  • 6Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology, 1995,108(3):865-869.
  • 7Patel AH, Hamois DM, Klee GC et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 2000,95(1):204-207.
  • 8Hultcrantz R, Olsson R, Danielsson A, et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol, 1999,30(4):669-673.
  • 9Gores GJ. Early detection and treatment of cholan- giocarcinoma. Liver Transpl, 2000,6(6 Suppl):S30-S34.
  • 10Kuszyk BS, Soyer P, Bluemke DA, et al. Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging. Crit Rev Diagn Imaging, 1997,38(1):59-88.

同被引文献2

引证文献2

二级引证文献11

Journal of Huazhong University of Science and Technology(Medical Sciences)
2014年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部